We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Identifies Aspirin Resistance in Heart Patients

By HospiMedica staff writers
Posted on 28 Mar 2001
A new diagnostic test identifies heart patients who are nonresponsive to aspirin, so doctors can prescribe alternate anti-platelet drugs.

Recent studies have reported that up to 15-20% of all heart patients currently taking aspirin as a preventive tool do not respond appropriately to aspirin's ability to reduce platelet function or they have become resistant to aspirin over time. More...
The new assay enables doctors to detect and monitor a heart patient's response to aspirin when used for the prevention of heart attacks and strokes. The test could also be used to determine compliance in patients on an aspirin regimen.

The test, called Aspirincheck, requires only a urine sample and provides results in two days. It was developed by Esoterix Coagulation (Aurora, CO, USA), which provides technology-based laboratory services and information.

"Tradition dictates that we test to monitor the effectiveness of long-term medication such as lipid-lowering drugs, so it makes sense that we start testing to monitor aspirin's effectiveness as well,” said Alexander Duncan, M.D., of Emory University (Atlanta, GA, USA).



Related Links:
Esoterix Coagulation

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.